A Phase I, Open-Label, Parallel-Group, Single Dose, Non-Randomized Study to Compare the Pharmacokinetics of Avanafil in Male Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2011
At a glance
- Drugs Avanafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacokinetics
- Sponsors VIVUS
- 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jan 2011 Actual end date (February 2010) added as reported by ClinicalTrials.gov.
- 28 Apr 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.